Substance / Medication

Streptozocin

Overview

Active Ingredient
streptozocin
RxNorm CUI
10114
Labeler: ESTEVE PHARMACEUTICALS, S.A.Updated: 2025-10-06T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.
Meyer Tim, Qian Wendi, Caplin Martyn E et al. · Eur J Cancer · 2014
PMID: 24445147RCT
Pancreatic neuroendocrine tumours.
O'Grady H L, Conlon K C · Eur J Surg Oncol · 2008
PMID: 17967523Review
[Surgical treatment of pancreatic neoplasms].
Minni F · G Chir · 2008
PMID: 18419975Review
Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.
Nakakura Eric K, Bergsland Emily K · Hematol Oncol Clin North Am · 2007
PMID: 17548034Review
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.
Turner N C, Strauss S J, Sarker D et al. · Br J Cancer · 2010
PMID: 20234360TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Streptozocin (substance)
SNOMED CT
16915004
UMLS CUI
C0038432
RxNorm CUI
10114
Labeler
ESTEVE PHARMACEUTICALS, S.A.

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.